Methylene Blue-Based Combination Therapy with Amodiaquine Prevents Severe Malaria in an Experimental Rodent Model

• Asıl Yazarlar: Jérôme Dormoi (Yazar), Rémy Amalvict (Yazar), Mathieu Gendrot (Yazar), Bruno Pradines (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: MDPI AG, 2022-09-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Untreated malaria can progress rapidly to severe forms (<24 h). Moreover, resistance to antimalarial drugs is a threat to global efforts to protect people from malaria. Given this, it is clear that new chemotherapy must be developed. We contribute new data about using methylene blue (MB) to cure...